Literature DB >> 11708422

Vascular changes in psoriatic knee joint synovitis.

U Fiocco1, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione, S Todesco.   

Abstract

OBJECTIVE: To evaluate the diagnostic utility of standard arthroscopy supported by a computerized image analysis system; and to examine and quantify the macroscopic appearance of blood vessels in selected anatomical areas, comparing 2 groups of patients with PsA and RA with refractory knee joint synovitis (KJS) for vascular marking (VM) features and VM scores, as well as for the relationship between respective VM scores and local and systemic KJS disease activity indices.
METHODS: Standard arthroscopy was carried out on 39 knees (20 PsA, 19 RA). Videorecordings of the examination were reanalyzed using a computer image analysis system and software. The appearance of vascular markings was assessed and separately scored for the areas of surface synovium (capsular, CVM), villous proliferation (villous, VVM), and synovium adherent to cartilage (pannus, PVM). Indices of systemic (erythrocyte sedimentation rate, ESR) and local KJS disease activity (clinical index) were obtained before arthroscopy. The morphology and scores of the distinct VM were compared between PsA and RA groups, as was the relationship between respective VM scores and ESR and KJS clinical indices.
RESULTS: Distinctive VM features were observed for PsA and RA KJS in each separate synovial architecture examined. VVM and CVM scores were significantly correlated with each other in PsA knees, and were significantly higher in PsA compared with RA. In both diseases, VVM and CVM scores were not related to KJS duration or activity or to ESR values, but in RA they were directly correlated with KJS activity. Moreover, the VVM capillary feature "meandering with tight convolutions," considered unique to psoriatic skin, was observed in the synovium of 13 PsA (65%) and one RA KJS (5.5%). The mean KJS duration of the PsA group with typical VVM was significantly lower than the group without VVM (2.6 +/- 1.77 vs 9.4 +/- 8.28 yrs).
CONCLUSION: Our macroscopic observations of distinct changes in VM expression in selected anatomical areas of PsA and RA KJS suggest possible pathogenetic differences between the 2 diseases. The typical morphology and higher intensity of villous vascularization, in both early and chronic disease, and the different clinical relevance of VVM scores in PsA compared with RA KJS support the potential use of vascular markings as reliable outcome measures of the PsA process in KJS.

Entities:  

Mesh:

Year:  2001        PMID: 11708422

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

1.  Lack of effect of corticosteroid injection at the shoulder joint on blood glucose levels in diabetic patients.

Authors:  George S Habib; Ramez Abu-Ahmad
Journal:  Clin Rheumatol       Date:  2006-06-29       Impact factor: 2.980

2.  Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis.

Authors:  Ugo Fiocco; Roberto Stramare; Alessandro Coran; Enrico Grisan; Elena Scagliori; Francesco Caso; Luisa Costa; Francesca Lunardi; Francesca Oliviero; Fulvia Chieco Bianchi; Anna Scanu; Veronica Martini; Daniele Boso; Valeria Beltrame; Maristella Vezzù; Luisella Cozzi; Raffaele Scarpa; David Sacerdoti; Leonardo Punzi; Andrea Doria; Fiorella Calabrese; Leopoldo Rubaltelli
Journal:  Clin Rheumatol       Date:  2015-02-14       Impact factor: 2.980

3.  Pixel-based approach to assess contrast-enhanced ultrasound kinetics parameters for differential diagnosis of rheumatoid arthritis.

Authors:  Gaia Rizzo; Bernd Raffeiner; Alessandro Coran; Luca Ciprian; Ugo Fiocco; Costantino Botsios; Roberto Stramare; Enrico Grisan
Journal:  J Med Imaging (Bellingham)       Date:  2015-09-11

Review 4.  Imaging in psoriatic arthritis.

Authors:  Allen Anandarajah
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

5.  Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints.

Authors:  Ugo Fiocco; Roberto Stramare; Veronica Martini; Alessandro Coran; Francesco Caso; Luisa Costa; Mara Felicetti; Gaia Rizzo; Matteo Tonietto; Anna Scanu; Francesca Oliviero; Bernd Raffeiner; Maristella Vezzù; Francesca Lunardi; Raffaele Scarpa; David Sacerdoti; Leopoldo Rubaltelli; Leonardo Punzi; Andrea Doria; Enrico Grisan
Journal:  Clin Rheumatol       Date:  2016-12-20       Impact factor: 2.980

6.  Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept.

Authors:  U Fiocco; F Ferro; M Vezzù; L Cozzi; C Checchetto; P Sfriso; C Botsios; L Ciprian; G Armellin; R Nardacchione; A Piccoli; S Todesco; L Rubaltelli
Journal:  Ann Rheum Dis       Date:  2004-11-26       Impact factor: 19.103

7.  Macroscopic features of knee synovitis in early untreated Behçet disease and psoriatic arthritis.

Authors:  Concepción Moll; Mónica Bogas; José A Gómez-Puerta; Raquel Celis; Ivonne Vázquez; Fernando Rodríguez; Eduardo Kanterewicz; Raimón Sanmarti; Juan D Cañete
Journal:  Clin Rheumatol       Date:  2009-06-09       Impact factor: 2.980

8.  Capillaroscopic pattern in inflammatory arthritis.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Microvasc Res       Date:  2012-03-09       Impact factor: 3.514

9.  A sonographic spectrum of psoriatic arthritis: "the five targets".

Authors:  Marwin Gutierrez; Emilio Filippucci; Rossella De Angelis; Giorgio Filosa; David Kane; Walter Grassi
Journal:  Clin Rheumatol       Date:  2009-10-24       Impact factor: 2.980

Review 10.  What magnetic resonance imaging has told us about the pathogenesis of rheumatoid arthritis--the first 50 years.

Authors:  Dennis McGonagle; Ai Lyn Tan
Journal:  Arthritis Res Ther       Date:  2008-10-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.